mouse Lilr4b antibody | antibody review based on formal publications

This is a Validated Antibody Database (VAD) review about mouse Lilr4b, based on 4 published articles (read how Labome selects the articles), using Lilr4b antibody in all methods. It is aimed to help Labome visitors find the most suited Lilr4b antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

Lilr4b synonym: Gp49a; gp49

BioLegend

hamsters monoclonal (H1.1) 144905	flow cytometry; mouse; 1:200; loading ...	BioLegend Lilr4b antibody (Biolegend, 144905) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
hamsters monoclonal (H1.1) 144906 144905 144902 144907 144909	flow cytometry; mouse; 1:100; loading ...; fig 2g	BioLegend Lilr4b antibody (BioLegend, H1.1) was used in flow cytometry on mouse samples at 1:100 (fig 2g). Nat Immunol (2021) ncbi
hamsters monoclonal (H1.1) 144906 144905 144904 144903 144902 144907	flow cytometry; mouse; 1:200; loading ...; fig 2d	BioLegend Lilr4b antibody (Biolegend, H1.1) was used in flow cytometry on mouse samples at 1:200 (fig 2d). Cell Rep (2019) ncbi
hamsters monoclonal (H1.1) 144903	flow cytometry; mouse; loading ...; fig s1g	BioLegend Lilr4b antibody (Biolegend, 144903) was used in flow cytometry on mouse samples (fig s1g). Cell (2019) ncbi

Articles Reviewed

James O, Vandereyken M, Marchingo J, Singh F, Bray S, Wilson J, et al. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes. Nat Commun. 2021;12:4290 pubmed publisher
Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher

contribute

If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.

questions and comments